** Shares of healthcare technology co Aclarion ACON.O rise 68% to $5.61 premarket
** Co says it has entered into commercial agreement with Scripps Health
** The agreement will bring ACON's Nociscan, a tool that helps physicians personalize treatment for chronic low back pain, to Scripps' physicians in California
** In the last 12 months, ACON has fallen nearly 98%
(Reporting by Siddhi Mahatole)
((Siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。